Larson Financial Group LLC Purchases 3,264 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Larson Financial Group LLC raised its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 49.9% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 9,803 shares of the pharmacy operator’s stock after acquiring an additional 3,264 shares during the period. Larson Financial Group LLC’s holdings in Walgreens Boots Alliance were worth $88,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of the company. Inlet Private Wealth LLC boosted its position in Walgreens Boots Alliance by 1.9% during the 2nd quarter. Inlet Private Wealth LLC now owns 47,820 shares of the pharmacy operator’s stock valued at $578,000 after acquiring an additional 900 shares in the last quarter. Capital Investment Counsel Inc boosted its position in Walgreens Boots Alliance by 6.6% during the 2nd quarter. Capital Investment Counsel Inc now owns 15,340 shares of the pharmacy operator’s stock valued at $186,000 after acquiring an additional 950 shares in the last quarter. Continuum Advisory LLC boosted its position in Walgreens Boots Alliance by 71.2% during the 2nd quarter. Continuum Advisory LLC now owns 2,453 shares of the pharmacy operator’s stock valued at $30,000 after acquiring an additional 1,020 shares in the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd boosted its position in Walgreens Boots Alliance by 1.6% during the 2nd quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 65,690 shares of the pharmacy operator’s stock valued at $795,000 after acquiring an additional 1,038 shares in the last quarter. Finally, Sequoia Financial Advisors LLC boosted its position in shares of Walgreens Boots Alliance by 4.4% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 25,215 shares of the pharmacy operator’s stock worth $226,000 after purchasing an additional 1,063 shares in the last quarter. 58.59% of the stock is owned by institutional investors.

Walgreens Boots Alliance Price Performance

Shares of Walgreens Boots Alliance stock opened at $9.06 on Friday. Walgreens Boots Alliance, Inc. has a one year low of $8.08 and a one year high of $27.05. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.37 and a current ratio of 0.68. The stock has a market cap of $7.83 billion, a P/E ratio of -0.91, a P/E/G ratio of 1.14 and a beta of 0.69. The stock’s fifty day moving average is $9.14 and its 200 day moving average is $11.36.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.36 by $0.03. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The business had revenue of $37.50 billion during the quarter, compared to analyst estimates of $35.75 billion. During the same quarter in the prior year, the business posted $0.67 EPS. Walgreens Boots Alliance’s revenue for the quarter was up 5.9% compared to the same quarter last year. Sell-side analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.53 earnings per share for the current year.

Walgreens Boots Alliance Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, December 12th. Shareholders of record on Monday, November 18th will be paid a $0.25 dividend. The ex-dividend date is Monday, November 18th. This represents a $1.00 dividend on an annualized basis and a yield of 11.04%. Walgreens Boots Alliance’s payout ratio is presently -9.99%.

Analyst Ratings Changes

A number of analysts have recently commented on WBA shares. Truist Financial dropped their price target on Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating on the stock in a research report on Monday, October 7th. TD Cowen dropped their price target on Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating on the stock in a research report on Tuesday, October 22nd. UBS Group boosted their price target on Walgreens Boots Alliance from $9.00 to $10.00 and gave the stock a “neutral” rating in a research report on Thursday, October 17th. Barclays boosted their price target on Walgreens Boots Alliance from $7.00 to $8.00 and gave the stock an “underweight” rating in a research report on Wednesday, October 16th. Finally, Evercore ISI boosted their price objective on shares of Walgreens Boots Alliance from $7.50 to $10.00 and gave the stock an “in-line” rating in a report on Wednesday, October 16th. Four investment analysts have rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, Walgreens Boots Alliance presently has an average rating of “Hold” and a consensus target price of $12.88.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.